Prof. Raymond J. Tuner, CSO and Co-founder of MHCombotic, speaks about the technology
Exploring how research and entrepreneurship are shaping the future of antimicrobial solutions.
Mitacs showcases Dr. Ali Pormohammad's journey from research to building MHCombiotic and advancing antimicrobial innovation.
MHCombiotic CEO Dr. Ali Pormohammad joins BIO-Europe Spring to showcase innovations tackling antimicrobial resistance.
Genome Alberta is supporting the clinical validation of ComBatic™ to advance innovative wound care and combat antimicrobial resistance.
Discover how Dr. Ali Pormohammad and MHCombiotic are advancing antimicrobial innovation through research and entrepreneurship at UCalgary.
MTEC highlights MHCombiotic's innovative antimicrobial technologies for wound care, respiratory infections, and biofilm disruption.
Scale Up Canada recognized MHCombiotic as one of Calgary's Top 50 Most Scalable Startups for its innovative antimicrobial technology.
MHCombiotic was spotlighted at Collision 2024 for its innovative antimicrobial technology and mission to combat antimicrobial resistance.
UCalgary spotlights MHCombiotic and founder Dr. Ali Pormohammad, showcasing the startup's mission to combat antimicrobial resistance through innovation.
MaRS highlights MHCombiotic's innovative antimicrobial platform designed to combat biofilms and antimicrobial resistance.
MHCombiotic receives Government of Canada funding to validate ComBatic™ and support Health Canada and FDA regulatory submissions.
MHCombiotic receives Alberta Innovates funding to advance its ComBatic™ antimicrobial wound care technology.
Discover how MHCombiotic's ComBatic™ technology helps prevent infection and eradicate biofilms in challenging care environments.
NPC is helping MHCombiotic advance its natural antimicrobial wound care solution through commercialization funding and strategic support.
MHCombiotic has been recognized as a 2024 Game Changer by Natural Products Canada for its innovative antimicrobial solutions.
Recognized for advancing biotech innovation and impactful healthcare solutions.
Transforming postdoctoral research into real-world antimicrobial breakthroughs.
Thanks for subscribing!
This email has been registered!